Abionic

At Abionic we are focused on delivering true patient-centric diagnosis solutions, which means a rapid, reliable test available at any time, from anywhere, whenever a patient needs it… A potential to save millions of lives is what drives us to work hard every day. We are committed to creating a positive workplace environment and a culture of trust that support dedicated teamwork. Abionic has received numerous awards since it was founded in 2010. Abionic was founded as a spin-off from the EPFL. Abionic, based in the Biopôle life sciences campus in Lausanne, Switzerland, is developing and manufacturing in vitro diagnostic solutions using its proprietary disruptive nanofluidic technology. We believe that our rapid, laboratory-quality diagnostic solutions enable physicians to make early, appropriate clinical decisions at the point of need. Our manufacturing line has been designed to meet the highest international medical standards with a current capacity of 1 million tests produced annually. Our dynamic team is highly effective, and we are committed to changing the world of in vitro diagnostics (IVD) by bringing rapid diagnostic solutions close to the patient.